Biblio

Author Title Type [ Year

]

Filters: Author is Zhang, Yanqi [Clear All Filters]

2022

Zhu Y, Zhang Z, Fan N, Huang K, Li H, Gu J, Zhang Q, Ouyang Z, Zhang T, Tang J, et al. Generating functional cells through enhanced interspecies chimerism with human pluripotent stem cells. Stem Cell Reports. 2022.

Zhang D, Zhou M, Zhang Y, Shan Y, Pan G. Generation of an RNF1-deficient human pluripotent stem cell line using CRISPR/Cas9 technology. Stem Cell Res. 2022;62:102809.

2021

Zhao Y, Wang T, Zhang Y, Shi L, Zhang C, Zhang J, Yao J, Chen Q, Zhong X, Wei Y, et al. Coordination of EZH2 and SOX2 specifies human neural fate decision. Cell Regen. 2021;10(1):30.

Zhang C, Wei Y, Zhang Y, Zhang J, Xing Q, Zhou M, Shan Y. Establishment of a CRISPR/Cas9-mediated ANP32A homozygous knockout human embryonic stem cell line. Stem Cell Res. 2021;52:102234.

2020

Gao L, Zhang Y, Wang S, Kong P, Su Y, Hu J, Jiang M, Bai H, Lang T, Wang J, et al. Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial. J Clin Oncol. 2020:JCO1903277.

Shan Y, Ma L, Zhang C, Zhang Y, Zhang J, Xiao L, Wei Y, Yu Y. Generation of two RNF2 homozygous knockout human embryonic stem cell lines by CRISPR/Cas9 system. Stem Cell Res. 2020;47:101885.